Skip to main content
Equibles

BLISSGVS · Bliss GVS Pharma Limited · Financials

Use BLISSGVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BLISSGVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
673.00 INR +31.85 (+4.97%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 32.67K Avg daily vol (3M) 22.68K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
9.27B +14.5%
FY2026 Revenue FY2019–FY2026
Net Income
1.29B +53.2%
FY2026 Net Income FY2019–FY2026
Operating Cash Flow
1.39B +31%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
INR 10.74B 9.27B 8.1B 7.7B 7.52B 7.47B 5.77B 6.89B 8.98B
INR 374.54M 334.83M 294.18M 263.8M 186.73M 173.31M 172.3M 125.89M 89.44M
INR 73.69M 120.07M 81.2M 69.12M 103.64M 47.42M 55.14M 54.09M 44.15M
INR 2.36B 1.9B 1.26B 1.17B 1.06B 541.65M 1.04B 1.29B 1.82B
INR 699.35M 548.62M 353.84M 352.94M 293.37M 310.39M 301.55M 337.12M 552.5M
INR 1.61B 1.29B 842.99M 754.54M 708.59M 150.4M 684.91M 972.65M 1.34B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 323.52M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.